金城医药8月25日获融资买入7783.59万元，融资余额4.06亿元

Group 1 - The stock of Jincheng Pharmaceutical increased by 4.92% on August 25, with a trading volume of 891 million yuan [1] - On the same day, the financing buy amount was 77.84 million yuan, while the financing repayment was 114 million yuan, resulting in a net financing outflow of 36.60 million yuan [1] - As of August 25, the total balance of margin trading for Jincheng Pharmaceutical was 407 million yuan, with a financing balance of 406 million yuan, accounting for 5.40% of the circulating market value [1] Group 2 - As of August 20, the number of shareholders for Jincheng Pharmaceutical was 34,200, a decrease of 9.39% from the previous period [2] - The average circulating shares per person increased by 10.36% to 10,884 shares [2] - For the first half of 2025, the company reported a revenue of 1.36 billion yuan, a year-on-year decrease of 22.65%, and a net profit attributable to shareholders of 43.38 million yuan, down 66.78% year-on-year [2] Group 3 - Since its A-share listing, Jincheng Pharmaceutical has distributed a total of 895 million yuan in dividends, with 285 million yuan distributed in the last three years [3] - As of June 30, 2025, Hong Kong Central Clearing Limited was the third-largest circulating shareholder, holding 5.47 million shares, a decrease of 525,100 shares from the previous period [3]